INVA (Innoviva, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by INVA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-24 | Stephen Basso | Chief Financial Officer | F | — | — |
| 2026-08-24 | Marianne Zhen | Chief Accounting Officer | F | — | — |
| 2026-08-24 | Pavel Raifeld | Chief Executive Officer | F | — | — |
| 2026-05-22 | Stephen Basso | Chief Financial Officer | MIXED | — | — |
| 2026-05-22 | Marianne Zhen | Chief Accounting Officer | F | — | — |
| 2026-05-22 | Pavel Raifeld | Chief Executive Officer | MIXED | — | — |
| 2026-05-20 | Josephine Linden | Director | A | — | — |
| 2026-05-06 | Pavel Raifeld | Chief Executive Officer | A | — | — |
| 2026-05-06 | Stephen Basso | Chief Financial Officer | A | — | — |
| 2026-05-06 | Mark DiPaolo | Director | A | — | — |
| 2026-05-06 | Jules Haimovitz | Director | A | — | — |
| 2026-05-06 | Sarah J. Schlesinger | Director | A | — | — |
| 2026-05-06 | Marianne Zhen | Chief Accounting Officer | A | — | — |
| 2026-05-06 | Derek A Small | Director | A | — | — |
| 2026-02-24 | Marianne Zhen | Chief Accounting Officer | F | — | — |
| 2026-02-24 | Pavel Raifeld | Chief Executive Officer | F | — | — |
| 2026-02-24 | Stephen Basso | Chief Financial Officer | F | — | — |
| 2025-11-24 | Marianne Zhen | Chief Accounting Officer | F | — | — |
| 2025-11-24 | Stephen Basso | Chief Financial Officer | MIXED | — | — |
| 2025-11-05 | Stephen Basso | Chief Financial Officer | A | — | — |
| 2025-11-05 | Pavel Raifeld | 10%+ Owner | A | — | — |
| 2025-08-22 | Stephen Basso | Chief Financial Officer | F | — | — |
| 2025-08-22 | Marianne Zhen | Chief Accounting Officer | F | — | — |
| 2025-05-22 | Marianne Zhen | Chief Accounting Officer | F | — | — |
| 2025-05-22 | Stephen Basso | Chief Financial Officer | MIXED | — | — |
| 2025-05-21 | Jules Haimovitz | Director | A | — | — |
| 2025-05-21 | Derek A Small | Director | A | — | — |
| 2025-05-21 | Sarah J. Schlesinger | Director | A | — | — |
| 2025-05-21 | Mark DiPaolo | Director | A | — | — |
| 2025-03-26 | Stephen Basso | Chief Financial Officer | A | — | — |
| 2025-03-26 | Pavel Raifeld | 10%+ Owner | A | — | — |
| 2025-03-26 | Marianne Zhen | Chief Accounting Officer | A | — | — |
| 2025-03-06 | Sarissa Capital Management LP | 10%+ Owner | Sell | — | — |
| 2025-02-24 | Marianne Zhen | Chief Accounting Officer | F | — | — |
| 2025-02-24 | Stephen Basso | Chief Financial Officer | MIXED | — | — |
| 2024-11-22 | Marianne Zhen | Chief Accounting Officer | MIXED | — | — |
| 2024-08-22 | Marianne Zhen | Chief Accounting Officer | F | — | — |
| 2024-06-20 | Kostas D Odysseas | Director | A | — | — |
| 2024-06-20 | Jules Haimovitz | Director | A | — | — |
| 2024-06-20 | Sapna Srivastava | Director | A | — | — |
| 2024-06-20 | Sarah J. Schlesinger | Director | A | — | — |
| 2024-06-20 | Derek A Small | Director | A | — | — |
| 2024-06-20 | Mark DiPaolo | Director | A | — | — |
| 2024-05-21 | Marianne Zhen | Chief Accounting Officer | F | — | — |
| 2024-05-21 | Matthew Ronsheim | See Remarks | F | — | — |
| 2024-03-07 | Matthew Ronsheim | See Remarks | A | — | — |
| 2024-03-07 | Pavel Raifeld | Chief Executive Officer | A | — | — |
| 2024-03-07 | Stephen Basso | Chief Financial Officer | A | — | — |
| 2024-03-07 | Marianne Zhen | Chief Accounting Officer | A | — | — |
| 2024-02-22 | Matthew Ronsheim | See Remarks | F | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 6,855,451 | — |
| — | President & Chief Exec Officer | 980,907 | — |
| — | SVP and CFO | 376,965 | — |
| — | Sr. VP & Chief Comm. Officer | 293,479 | — |
| — | Chief Executive Officer | 284,799 | — |
| — | Sr VP & Chief Business Officer | 279,422 | — |
| — | Sr. VP & Chief Scientific Off. | 247,767 | — |
| — | Director | 161,789 | — |
| — | Director | 152,692 | — |
| — | Director | 140,492 | — |
| — | Director | 140,492 | — |
| — | Director | 137,207 | — |
| — | Director | 122,625 | — |
| — | Chief Financial Officer | 88,013 | — |
| — | Director | 73,805 | — |
| — | Director | 73,805 | — |
| — | Director | 70,554 | — |
| — | Director | 58,984 | — |
| — | Director | 58,278 | — |
| — | Chief Accounting Officer | 56,389 | — |
| — | Director | 52,318 | — |
| — | Interim Principal Exec Officer | 49,751 | — |
| — | Director | 45,035 | — |
| — | Director | 44,096 | — |
| — | See Remarks | 40,510 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the INVA quote page; the site-wide leaderboard is on the insider transactions hub.